A股开盘：沪指跌0.69% 贵金属领跌

Medipost Reports Positive Phase 3 Results for CARTISTEM in Japan’s Knee Osteoarthritis Trial_蜘蛛资讯网

nbsp; Lee Seung-jin, Head of Medipost’s Global Business Division and CEO of its Japanese subsidiary, is speaking at a press conference to announce the results of the Phase 3 clinical trial for Ca

s (Kellgren–Lawrence Grade 2-3) across 13 medical institutions. Participants were divided into two groups: 59 patients received CARTISTEM, while 61 received hyaluronic acid (HA) injections. The

当前文章：http://vb8.mushenlu.cn/eccs3mn/oukp.html

发布时间：00:00:00